Opioid Maker Insys Still Has Fans on Wall Street

Insys is developing two different cannabinoid drugs that patients can take orally or inhale, along with different spray treatments, which aim to treat problems including children's epilepsy and opioid dependence. “The shorts have been right on the stock,” Mr. Trbovich said. “I still think I'm right on the ...